v3 Template
V

Vesalius Biocapital

Life Sciences / Healthcare ~50 employees
Founded
--
Employees (Est.)
~50
5 leaders known
Total Funding
$103.7M
Funding Rounds
1
Last Funding
2023-06-29

About Vesalius Biocapital

Vesalius Biocapital Partners Sàrl is a venture capital firm that invests in young, innovative European life science companies focused on human health. Since 2007, they have supported the development of 20 companies and aim to be the lead investor in most financing rounds.

Products & Services

Venture Capital Funds: Provides financial backing to early-stage and developing life science companies in Europe with a focus on proprietary technology, unique team skills, and competitive edge.

Specialties

Therapeutics Medical Devices Diagnostics

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Venture Capital Fund (Fourth Fund - Vesalius Biocapital IV)
T: -
FT: Venture Capital Fund (Fourth Fund - Vesalius Biocapital IV)
A: 103700000
MR: -
FA: EUR 95 million
FAN: 103700000
D: 2023-06-29
FD: 2023-06-29
1 investors
Venture Capital Fund (Fourth Fund - Vesalius Biocapital IV) Latest
2023-06-29
$103.7M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

G

Gaston Matthyssens

Managing Partner

A

Alain Parthoens

Managing Partner

C

Christian Schneider

Managing Partner

S

Stephane Verdood

Managing Partner

G

Guy Geldhof

Partner

View 2 more team members with Pro

Unlock Full Team Directory

Recent News

Vesalius Biocapital Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Life Sciences / Healthcare
Company Size
~50 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro